An Extension Study of JR-141 in Patients With Mucopolysaccharidosis Type II
Clinical trial NCT04348136 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04348136
- Sponsor
- JCR Pharmaceuticals Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-01
- Primary completion
- 2030-03-31
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.